Search Within

Population Sciences Research Program

  1. "Division of Subspecialty Medicine "
  2. "Sloan Kettering Institute Postdocs"
  3. "Steven Horwitz"
Formats
  1. Meeting Abstract (14)
  2. Journal Article (9)
  3. Research Letter (2)
  4. Review (1)
Groups
  1. Center for Hematologic Malignancies (26)
  2. Department of Medicine (26)
  3. Division of Subspecialty Medicine (26)
  4. Hematologic Malignancies, Division of (26)
  5. Lymphoma (26)
  6. Sloan Kettering Institute Postdocs (26)

More Groups

People
  1. Steven Horwitz (26)
  2. Patricia Myskowski (25)
  3. Alison Moskowitz (21)
  4. Melissa Pulitzer (17)
  5. Shamir Geller (16)
  6. Ahmet Dogan (7)

More People

Years
  1. 2023 (3)
  2. 2021 (2)
  3. 2020 (5)
  4. 2019 (8)
  5. 2018 (3)
  6. 2017 (2)

More Years

Publications
  1. Blood (8)
  2. Histopathology (2)
  3. Journal of Investigative Dermatology (2)
  4. Journal of the American Academy of Dermatology (2)
  5. Blood Cancer Journal (1)
  6. British Journal of Dermatology (1)

More Publications

Publishers
  1. American Society of Hematology (8)
  2. Wiley Blackwell (4)
  3. Elsevier Inc. (2)
  4. Elsevier Science, Inc. (2)
  5. Mosby Elsevier (2)
  6. Nature Publishing Group (2)

More Publishers

Results (26)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cutaneous T-cell lymphoma and dupilumab use: A retrospective matched cohort study of clinical characteristics and treatment outcomes
    Meeting Abstract

    Stuver, R.; Dusza, S.; Epstein-Peterson, Z. D.; Ghione, P.; Johnson, W.; Moskowitz, A.; Myskowski, P.; Pulitzer, M.; Horwitz, S. M.; Geller, S.
    Blood (2023)

    Fulltext@MSK | Save
  • Infectious complications in patients with relapsed or refractory (R/R) Non-Hodgkin's lymphoma (NHL) treated with the anti-CD20xCD3 bispecific antibody (BsAb) mosunetuzumab
    Meeting Abstract

    Shahid, Z.; Okwali, M.; Joseph, A.; Seo, S. K.; Lue, J. K.; Boardman, A. P.; Caron, P.; David, K. A.; Epstein-Peterson, Z. D.; Ghione, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Reduced dose brentuximab vedotin for mycosis fungoides appears to prolong response duration by balancing efficacy and tolerability
    Meeting Abstract

    Munayirji, B.; Khan, N.; Myskowski, P.; Geller, S.; Noor, S.; Kheterpal, M. K.; Davey, T.; Hancock, H.; Perez, L.; Miller, T.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Clinical outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg type treated in the rituximab era: Long-term follow-up of a single-center experience
    Meeting Abstract

    Falchi, L.; Qiu, A.; Ewalt, M. D.; Batlevi, C. L.; Caron, P. C.; Hamlin, P. A.; Hamilton, A.; Horwitz, S. M.; Joffe, E.; Khan, N.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas
    Journal Article

    Moskowitz, A. J.; Ghione, P.; Jacobsen, E.; Ruan, J.; Schatz, J. H.; Noor, S.; Myskowski, P.; Vardhana, S.; Ganesan, N.; Hancock, H.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Multispectral immunofluorescence identifies pS6 as a biomarker of intrinsic resistance to ruxolitinib in patients with relapsed/refractory T-cell lymphomas
    Meeting Abstract

    Ghione, P.; Moskowitz, A.; Kumar, P.; Knezevic, A.; Seshan, V.; Jacobsen, E.; Ruan, J.; Schatz, J.; Noor, S.; Myskowski, P.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Targeted genomic analysis of cutaneous T cell lymphomas identifies a subset with aggressive clinicopathological features
    Research Letter

    Argyropoulos, K. V.; Pulitzer, M.; Maura, F.; Mohanty, A.; Mondello, P.; Horwitz, S. M.; Myskowski, P.; Moskowitz, A.; Dogan, A.; Querfeld, C.; more...
    Blood Cancer Journal (2020)

    Fulltext@MSK | Save
  • Alternative anti-CD20 antibody versus desensitization for lymphoma patients with drug hypersensitivity reactions requiring discontinuation of rituximab, obinutuzumab, or ofatumumab
    Meeting Abstract

    Ghione, P.; Joffe, E.; De Paola, N.; Mainardi, T.; Noor, S. J.; Bobillo, S.; Myskowski, P. L.; Palomba, M. L.; Moskowitz, A. J.; Mato, A. R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Outcomes and prognostic factors in African American and black patients with mycosis fungoides/Sézary syndrome: Retrospective analysis of 157 patients from a referral cancer center
    Journal Article

    Geller, S.; Lebowitz, E.; Pulitzer, M. P.; Horwitz, S. M.; Moskowitz, A. J.; Dusza, S.; Myskowski, P. L.
    Journal of the American Academy of Dermatology (2020)

    Fulltext@MSK | Save
  • C-C chemokine receptor 4 expression in CD8+ cutaneous T-cell lymphomas and lymphoproliferative disorders, and its implications for diagnosis and treatment
    Journal Article

    Geller, S.; Hollmann, T. J.; Horwitz, S. M.; Myskowski, P. L.; Pulitzer, M.
    Histopathology (2020)

    Fulltext@MSK | Save